John L. Brottem sold $956 of OM
General Counsel at Outset Medical, Inc.. 224 shares at an average of $4.27, traded Jan 7, 2026, filed Jan 8, 2026.
Score components
- +15RoleOfficer
- 0Trade size$956 at market
- 0Share of holdings soldSold 0.5% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001484612-26-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 7, 2026 | SOpen-market sale Common Stock | -224 | $4.27 | $956 | 46,271 | Jan 8, 2026 |
Related signals
Other insiders at Outset Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | OMbuy Outset Medical, Inc. | Braden Michael Leonard owner | $870k 244,909 shares | +10% | |
| 15Weak | OMsell Outset Medical, Inc. | John L. Brottem General Counsel | $9,761 2,638 shares | -8% | |
| 30Weak | Outset Medical, Inc. | John L. Brottem General Counsel | $9,521 2,842 shares | -8% | |
| 30Weak | Outset Medical, Inc. | Marc Nash EVP Operations R&D & Service | $6,087 1,817 shares | -4% | |
| 40Moderate | Outset Medical, Inc. | Leslie Trigg Chair and CEO | $11k 3,361 shares | -3% | |
| 42Moderate | Outset Medical, Inc. | John L. Brottem General Counsel | $54k 10,494 shares | -23% | |
| 40Moderate | Outset Medical, Inc. | Marc Nash EVP Operations R&D & Service | $32k 6,355 shares | -13% | |
| 53Moderate | Outset Medical, Inc. | Leslie Trigg Chair and CEO | $71k 13,914 shares | -12% | |
| 30Weak | Outset Medical, Inc. | Marc Nash EVP Operations R&D & Service | $461 108 shares | -0% | |
| 40Moderate | Outset Medical, Inc. | Leslie Trigg Chair and CEO | $7,665 1,795 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.